Rate of Venous Thromboembolism Increased With Cancer Surgery
Cause-specific hazard ratio for pulmonary embolism peaked after discharge, then plateaued 60 to 90 days later
Strategy Needed to Address Impending Physician Shortage
AAMC promotes multipronged approach including federal support, technology, care delivery changes
Willingness to Use Videohealth Increased During Pandemic
Increase especially pronounced for Black adults and adults with lower educational attainment
Immunogenic Cancer Vaccine Targets Key Mutations in Kidney Cancer
Personalized vaccine targets key driver mutations and induces antitumor immunity in fully resected high-risk clear cell renal cell carcinoma
Nivolumab Plus Ipilimumab Tops Sunitinib for Advanced Renal CA
Overall survival, objective response higher than sunitinib for untreated clear-cell advanced RCC
Leukocyte Glucose Index, Arteriovenous Fistula Failure Linked in ESKD
Risk for AVF failure significantly higher for patients with higher baseline LGI, independent of age, sex, CV risk factors
FDA Approves ‘Biosimilar’ Drug to Treat Certain Types of Anemia
Retacrit is biosimilar to the drugs Epogen and Procrit
Interventions Up Discussion of Advanced Care Planning
Series of quality improvement interventions increases capture of advanced care directives in EMR
Novel Device Effective for Babies Requiring Renal Replacement Therapy
Newcastle Infant Dialysis Ultrafiltration System delivers accurate, controllable fluid removal and adequate clearance for babies under 8 kg
ASN: Empagliflozin Offers Lasting Cardiorenal Benefit in CKD Patients
Empagliflozin offers cardiorenal benefits for up to 12 months after discontinuation among CKD patients at risk for progression
